Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most ...
Jul 21, 2023
0
11
After 30 years of discouraging results in attempting to develop drugs to inhibit a mutated protein associated with some of the more challenging cancers to treat, research on RAS proteins is booming.
Jul 7, 2023
0
30
EPFL scientists have developed ClearTau, an innovative method and platform for reconstructing aggregates of the protein Tau found in Alzheimer's disease and other neurodegenerative diseases. The breakthrough may speed up ...
Jul 4, 2023
0
50
Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions that currently have limited treatment options: preterm births and fatty liver disease, two new studies ...
Jun 22, 2023
0
81
Ruxolitinib, a drug that is already approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers and skin conditions, is effective at inhibiting CaMKII, a protein kinase linked to cardiac arrhythmias.
Jun 21, 2023
1
66
A research team led by Junior Associate Professor Kazuo Takayama (CiRA, Kyoto University) and Professor Kei Sato (Institute of Medical Science, The University of Tokyo) experimentally infected human keratinocytes and human ...
Jun 20, 2023
0
5
My name is Antonio and I suffer from spinal muscular atrophy (SMA, for friends). My life expectancy was only a few years when I was born, almost half a century ago. And all because I "got" a rare, neurodegenerative disease, ...
Jun 15, 2023
1
5
Really, we should envy spiders. Imagine being able to make silk like they do, flinging it around to get from place to place, always having a strong-as-steel safety line or spinning a comfy hammock whenever they need a rest.
Jun 12, 2023
0
17
While most people survive and recover from COVID, for some people symptoms can persist for months or years. When symptoms last longer than 12 weeks, the condition is known as long COVID.
Jun 9, 2023
0
8
Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College ...
Jun 7, 2023
0
952
